NUREXONE BIOLOGIC INC. earnings per share and revenue

J90 earnings per share for the last quarter are -0.02 EUR whereas the estimation was -0.03 EUR which accounts for 33.33% surprise. Company revenue for the same period amounts to 0.00 EUR despite the estimated figure of 0.00 EUR. Estimated earnings per share for the next quarter are -0.02 EUR, and revenue is expected to reach 0.00 EUR. Also watch annual changes over time to get a bigger picture of J90 earnings per share and revenue dynamics.